Ariad Pharmaceuticals (ARIA) 8.08 $ARIA Why Ari
Post# of 64200
Posted On: 03/08/2015 5:20:57 PM
Ariad Pharmaceuticals (ARIA) 8.08 $ARIA
Why Ariad Pharmaceuticals, Inc. Catapulted 26% Higher in February
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 05, 7:02AM CST
What: Shares of Ariad Pharmaceuticals , a biopharmaceutical company primarily focused on discovering therapies to treat cancer, catapulted higher by 26% in February, based on data from S&P Capital IQ , following the release of its...
ARIA: 8.08 (-0.17)
Early Briefing on Biotech Industry Stocks -- ARIAD Pharma, Array BioPharma, Rexahn Pharma, Inotek Pharma, and Neurocrine Biosciences
PR Newswire - Tue Mar 03, 7:40AM CST
Editor Note: For more information about this release, please scroll to bottom.
RNN: 0.75 (-0.02), NBIX: 40.67 (-0.25), ITEK: 6.00 (unch), ARIA: 8.08 (-0.17), ARRY: 8.06 (-0.18)
Uptrend Call Working As Ariad Pharmaceuticals Stock Rises 12.2% (ARIA)
Comtex SmarTrend(R) - Mon Mar 02, 9:55AM CST
SmarTrend identified an Uptrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on December 22nd, 2014 at $7.12. In approximately 2 months, Ariad Pharmaceuticals has returned 12.22% as of today's recent price of $7.99.
ARIA: 8.08 (-0.17)
Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 27, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
CYTK: 7.80 (-0.11), VRX: 198.71 (-5.24), ACT: 289.92 (-5.78), PCYC: 254.56 (+0.34), MDT: 76.48 (-2.02), CAH: 87.01 (-1.94), CLDX: 29.39 (-0.39), HSP: 87.90 (+0.05), AGN: 233.51 (-1.90), JNJ: 100.11 (-2.41), ATOS: 1.97 (-0.04), ONVO: 5.59 (-0.13), PTCT: 71.13 (-1.59), SNY: 47.42 (-0.94), PTLA: 41.72 (-0.13), INCY: 90.00 (-1.97), PFE: 33.97 (-0.50), CPHR: 11.67 (-0.33), MYL: 55.44 (-1.25), AMGN: 154.88 (-4.72), LLY: 68.41 (-2.18), BMY: 65.12 (-0.93), MNKD: 5.47 (-0.26), NKTR: 13.02 (-0.28), OMER: 26.14 (-0.21), DVA: 77.63 (+0.70), GILD: 101.81 (-1.61), SGEN: 35.32 (-0.28), ACHN: 11.39 (+0.40), MRK: 56.84 (-1.14), TEVA: 56.40 (-0.11), BIL: 45.72 (-0.01), ARIA: 8.08 (-0.17), NVS: 97.46 (-1.49)
What Sarissa Capital's Proxy Fight Means For Ariad Investors
Investing Healthcare - at Seeking Alpha - Mon Feb 23, 7:53AM CST
AMRN: 1.78 (+0.11), VVUS: 2.79 (-0.08), ARIA: 8.08 (-0.17)
Nasdaq stocks posting largest percentage increases
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
PATK: 56.16 (-0.68), TILE: 19.90 (-0.24), DISCB: 33.59 (-1.31), DISCA: 33.08 (-0.48), CCRN: 11.01 (+0.05), EGLT: 14.05 (-1.13), DISCK: 31.77 (-0.38), PRQR: 22.86 (+1.49), AMOT: 25.23 (-1.66), ATRO: 69.15 (-2.21), ASMB: 14.41 (-0.22), ARIA: 8.08 (-0.17), UNTD: 17.02 (-0.72), WSCI: 6.12 (-0.01), SZMK: 7.75 (-0.47)
Most active Nasdaq-traded stocks
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 28.50 (-0.78), FB: 80.00 (-1.21), DISCB: 33.59 (-1.31), DISCA: 33.08 (-0.48), INTC: 33.19 (-0.54), DISCK: 31.77 (-0.38), MRVL: 16.56 (+0.05), AMAT: 23.91 (-0.27), ODP: 9.30 (-0.04), ARIA: 8.08 (-0.17), MSFT: 42.36 (-0.75), ZNGA: 2.54 (+0.13), AAPL: 126.60 (+0.19), CSCO: 28.92 (-0.38)
Arista and Noodles are big market movers
AP - Fri Feb 20, 4:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
FUEL: 10.34 (+0.02), NDLS: 17.49 (-0.58), ARIA: 8.08 (-0.17)
Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), CVM: 1.06 (-0.08), MDGN: 8.35 (+0.17), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), RPRX: 9.84 (-0.01), MNKD: 5.47 (-0.26), CELG: 118.03 (-2.68), SGEN: 35.32 (-0.28), TEVA: 56.40 (-0.11), ARIA: 8.08 (-0.17), SNY: 47.42 (-0.94), REGN: 422.13 (-6.82)
Why Ariad Pharmaceuticals, Inc. Stock Soared Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Feb 20, 2:38PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: After reporting fourth quarter and full...
ARIA: 8.08 (-0.17)
Ariad's largest shareholder starts proxy fight to oust CEO
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 9:12AM CST
VVUS: 2.79 (-0.08), ARIA: 8.08 (-0.17)
Activist Hedge Fund Seeks Firing of Ariad Pharma CEO Berger
at The Street - Fri Feb 20, 6:09AM CST
Activist hedge fund Sarissa Capital is starting a proxy fight to force the ouster of Ariad Pharmaceuticals founder and CEO Harvey Berger.
ARIA: 8.08 (-0.17)
ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 19, 1:41PM CST
ARIA: 8.08 (-0.17)
Ariad Pharmaceuticals ups revenues 695% in Q4
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 8:22AM CST
ARIA: 8.08 (-0.17)
ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 8:05AM CST
ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss
ARIA: 8.08 (-0.17)
Ariad reports 4Q loss
Automated Insights - Thu Feb 19, 7:43AM CST
CAMBRIDGE, Mass. (AP) _ Ariad Pharmaceuticals Inc. (ARIA) on Thursday reported a loss of $5.8 million in its fourth quarter.
ARIA: 8.08 (-0.17)
ARIAD Pharmaceuticals (ARIA) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 19, 7:25AM CST
ARIA: 8.08 (-0.17)
ARIAD Pharmaceuticals beats by $0.17, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 6:39AM CST
ARIA: 8.08 (-0.17)
Why Ariad Pharmaceuticals, Inc. Catapulted 26% Higher in February
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 05, 7:02AM CST
What: Shares of Ariad Pharmaceuticals , a biopharmaceutical company primarily focused on discovering therapies to treat cancer, catapulted higher by 26% in February, based on data from S&P Capital IQ , following the release of its...
ARIA: 8.08 (-0.17)
Early Briefing on Biotech Industry Stocks -- ARIAD Pharma, Array BioPharma, Rexahn Pharma, Inotek Pharma, and Neurocrine Biosciences
PR Newswire - Tue Mar 03, 7:40AM CST
Editor Note: For more information about this release, please scroll to bottom.
RNN: 0.75 (-0.02), NBIX: 40.67 (-0.25), ITEK: 6.00 (unch), ARIA: 8.08 (-0.17), ARRY: 8.06 (-0.18)
Uptrend Call Working As Ariad Pharmaceuticals Stock Rises 12.2% (ARIA)
Comtex SmarTrend(R) - Mon Mar 02, 9:55AM CST
SmarTrend identified an Uptrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on December 22nd, 2014 at $7.12. In approximately 2 months, Ariad Pharmaceuticals has returned 12.22% as of today's recent price of $7.99.
ARIA: 8.08 (-0.17)
Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 27, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
CYTK: 7.80 (-0.11), VRX: 198.71 (-5.24), ACT: 289.92 (-5.78), PCYC: 254.56 (+0.34), MDT: 76.48 (-2.02), CAH: 87.01 (-1.94), CLDX: 29.39 (-0.39), HSP: 87.90 (+0.05), AGN: 233.51 (-1.90), JNJ: 100.11 (-2.41), ATOS: 1.97 (-0.04), ONVO: 5.59 (-0.13), PTCT: 71.13 (-1.59), SNY: 47.42 (-0.94), PTLA: 41.72 (-0.13), INCY: 90.00 (-1.97), PFE: 33.97 (-0.50), CPHR: 11.67 (-0.33), MYL: 55.44 (-1.25), AMGN: 154.88 (-4.72), LLY: 68.41 (-2.18), BMY: 65.12 (-0.93), MNKD: 5.47 (-0.26), NKTR: 13.02 (-0.28), OMER: 26.14 (-0.21), DVA: 77.63 (+0.70), GILD: 101.81 (-1.61), SGEN: 35.32 (-0.28), ACHN: 11.39 (+0.40), MRK: 56.84 (-1.14), TEVA: 56.40 (-0.11), BIL: 45.72 (-0.01), ARIA: 8.08 (-0.17), NVS: 97.46 (-1.49)
What Sarissa Capital's Proxy Fight Means For Ariad Investors
Investing Healthcare - at Seeking Alpha - Mon Feb 23, 7:53AM CST
AMRN: 1.78 (+0.11), VVUS: 2.79 (-0.08), ARIA: 8.08 (-0.17)
Nasdaq stocks posting largest percentage increases
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
PATK: 56.16 (-0.68), TILE: 19.90 (-0.24), DISCB: 33.59 (-1.31), DISCA: 33.08 (-0.48), CCRN: 11.01 (+0.05), EGLT: 14.05 (-1.13), DISCK: 31.77 (-0.38), PRQR: 22.86 (+1.49), AMOT: 25.23 (-1.66), ATRO: 69.15 (-2.21), ASMB: 14.41 (-0.22), ARIA: 8.08 (-0.17), UNTD: 17.02 (-0.72), WSCI: 6.12 (-0.01), SZMK: 7.75 (-0.47)
Most active Nasdaq-traded stocks
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 28.50 (-0.78), FB: 80.00 (-1.21), DISCB: 33.59 (-1.31), DISCA: 33.08 (-0.48), INTC: 33.19 (-0.54), DISCK: 31.77 (-0.38), MRVL: 16.56 (+0.05), AMAT: 23.91 (-0.27), ODP: 9.30 (-0.04), ARIA: 8.08 (-0.17), MSFT: 42.36 (-0.75), ZNGA: 2.54 (+0.13), AAPL: 126.60 (+0.19), CSCO: 28.92 (-0.38)
Arista and Noodles are big market movers
AP - Fri Feb 20, 4:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
FUEL: 10.34 (+0.02), NDLS: 17.49 (-0.58), ARIA: 8.08 (-0.17)
Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), CVM: 1.06 (-0.08), MDGN: 8.35 (+0.17), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), RPRX: 9.84 (-0.01), MNKD: 5.47 (-0.26), CELG: 118.03 (-2.68), SGEN: 35.32 (-0.28), TEVA: 56.40 (-0.11), ARIA: 8.08 (-0.17), SNY: 47.42 (-0.94), REGN: 422.13 (-6.82)
Why Ariad Pharmaceuticals, Inc. Stock Soared Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Feb 20, 2:38PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: After reporting fourth quarter and full...
ARIA: 8.08 (-0.17)
Ariad's largest shareholder starts proxy fight to oust CEO
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 9:12AM CST
VVUS: 2.79 (-0.08), ARIA: 8.08 (-0.17)
Activist Hedge Fund Seeks Firing of Ariad Pharma CEO Berger
at The Street - Fri Feb 20, 6:09AM CST
Activist hedge fund Sarissa Capital is starting a proxy fight to force the ouster of Ariad Pharmaceuticals founder and CEO Harvey Berger.
ARIA: 8.08 (-0.17)
ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 19, 1:41PM CST
ARIA: 8.08 (-0.17)
Ariad Pharmaceuticals ups revenues 695% in Q4
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 8:22AM CST
ARIA: 8.08 (-0.17)
ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 8:05AM CST
ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss
ARIA: 8.08 (-0.17)
Ariad reports 4Q loss
Automated Insights - Thu Feb 19, 7:43AM CST
CAMBRIDGE, Mass. (AP) _ Ariad Pharmaceuticals Inc. (ARIA) on Thursday reported a loss of $5.8 million in its fourth quarter.
ARIA: 8.08 (-0.17)
ARIAD Pharmaceuticals (ARIA) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 19, 7:25AM CST
ARIA: 8.08 (-0.17)
ARIAD Pharmaceuticals beats by $0.17, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 6:39AM CST
ARIA: 8.08 (-0.17)
(0)
(0)